Medical Software Development in the United States: Compliance, Cost, and How to Ship Faster

Medical software development in the United States is defined less by the code than by the regulatory perimeter around it. Before a single screen reaches a patient, the product has to satisfy HIPAA, meet FDA expectations where it functions as a device, and exchange data cleanly under federal interoperability rules. That perimeter is what separates a healthcare build from an ordinary app, and it is why US teams face a familiar tension: they need enterprise-grade compliance, but US-only build costs strain the budget. This guide covers what actually counts as medical software in the US, the compliance landscape you have to clear, what it costs, why so many healthcare companies outsource to India, and how we approach the work at Ailoitte, including where AI genuinely helps.

What Counts as “Medical Software” in the US

Medical software in the US is a spectrum, and where a product sits on that spectrum decides which rules apply. The category spans EHR and EMR systems, practice management, revenue cycle management, telehealth and remote patient monitoring, patient engagement, clinical decision support, and Software as a Medical Device. That last category is where medical device software development formally begins, with FDA oversight layered on top of everything else.

The line that matters most is this: not all medical software is a regulated device. Health IT, such as an EHR module or a scheduling platform, sits under HIPAA and the federal health-IT framework. SaMD, software that performs a medical purpose on its own, adds FDA oversight on top. Getting this classification right early is the single most consequential decision in the build. If you are unsure which side of the line you are on, our classification guide for founders walks through the qualifying questions, and the deeper split between SaMD and SiMD explains why that one distinction reshapes your entire regulatory path.

The US Compliance Landscape

Compliant US medical software has to clear four overlapping layers: privacy, security, device regulation where applicable, and interoperability. Here is what each one asks of your build.

• HIPAA. The Privacy and Security Rules govern any software that touches protected health information, with HITECH raising the stakes and the HHS Office for Civil Rights enforcing them. Encryption, access control, and audit logging are table stakes, not features. Our HIPAA-compliant software development practice covers the engineering side in depth.
• Interoperability and information blocking. The 21st Century Cures Act prohibits information blocking and pushes standardized data sharing, which shapes how your product exposes and exchanges data.
• Certified health IT. Health IT that pursues certification works within the ONC Health IT Certification Program, now administered by ASTP/ONC, and lands on the Certified Health IT Product List.
• FDA for SaMD. Software that qualifies as a device follows a risk-based pathway, 510(k), De Novo, or PMA, built on the IEC 62304 software lifecycle and ISO 14971 risk management. Building to that standard is the core of medical device software development. Two recent shifts matter: the Quality Management System Regulation (QMSR) took effect on February 2, 2026, aligning FDA quality-system requirements with ISO 13485, and for adaptive AI, the Predetermined Change Control Plan (PCCP), whose final guidance issued in December 2024, lets you pre-specify model updates so you are not filing a fresh clearance for every refresh. Our IEC 62304 safety classes explainer shows how Class A, B, and C map to potential harm.
• Security attestations. Buyers expect SOC 2 and ISO 27001 as proof that your security program is real, not aspirational.
• State and interoperability layers. State privacy laws stack on top of federal rules, for example California’s Confidentiality of Medical Information Act, while HL7 FHIR R4 and USCDI are the practical backbone of clinical data exchange.

Compliance is also market-specific: a build for another jurisdiction follows a different rulebook, as our guide to hospital management system development in Australia illustrates for teams weighing a multi-market rollout.

What If Your Product Isn’t Covered by HIPAA?

If your product is not covered by HIPAA, it is not unregulated. Many US health apps and direct-to-consumer tools fall under the FTC instead, through its Health Breach Notification Rule and Section 5, and the FTC has enforced hard, with penalties against health apps like GoodRx and BetterHelp. State consumer-health-privacy laws add another layer: Washington’s My Health My Data Act, in effect since 2024, defines consumer health data broadly, requires opt-in consent, and carries a private right of action, so consumers can sue directly. We cover this fast-moving area in our guide to health app privacy beyond HIPAA.

FDA Cybersecurity and the SBOM Requirement

If your software is part of a connected medical device, cybersecurity is now a gating requirement, not a nice-to-have. Under Section 524B of the FD&C Act, in effect since March 2023, any “cyber device” premarket submission must include cybersecurity documentation and a machine-readable software bill of materials (SBOM), and the FDA can refuse to accept submissions that lack it. The requirement was updated again in February 2026 to align with the new QMSR. Our guide to FDA medical device cybersecurity and SBOMs breaks down what a compliant submission needs.

What US Medical Software Actually Costs

US medical software costs more than general software because compliance is engineered in, not bolted on. The real cost drivers are US developer rates, HIPAA and SOC 2 audit and validation overhead, EHR and FHIR integration complexity, security architecture, and the QA and validation cycles a regulated product demands.

Separate the build cost from the running cost. Maintenance, security patching, and compliance upkeep continue for the life of the product, so a realistic budget plans for both. The cost of getting it wrong belongs in the same conversation: OCR penalties and breach remediation dwarf the cost of doing it right the first time, which is why compliance spend is an investment rather than a tax.

Figures vary widely by device class, integration count, and regulatory pathway, so treat any single number with caution. Our medical device software development cost breakdown lays out where the money actually goes across classes and pathways.

Will It Get Reimbursed?

Building compliant software is only half the US equation; the other half is whether it gets paid for. Reimbursement runs on its own track through CMS coverage and CPT codes for remote patient monitoring (RPM) and remote therapeutic monitoring (RTM), and payer coverage often decides whether a product has a viable business. Plan the reimbursement pathway alongside the build, not after launch. Our guide to digital health reimbursement and CPT codes walks through the coding and coverage landscape.

Discover how Ailoitte AI keeps you ahead of risk

Let's Talk

Sunil Kumar

Sunil Kumar is CEO of Ailoitte, an AI-native engineering company building intelligent applications for startups and enterprises. He created the AI Velocity Pods model, delivering production-ready AI products 5× faster than traditional teams. Sunil writes about agentic AI, GenAI strategy, and outcome-based engineering. Connect on LinkedIn